Christine A Nash
CIK 1554403 · SVP & Chief Commercial Officer · last filed 2025-05-15
Christine A Nash is a SVP & Chief Commercial Officer who has filed 19 SEC Form 4 insider transactions across 2 companies since 2012. The most recent filing, for RLYB, was dated May 15, 2025. Across all open-market trades the lifetime net is −$1.5M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
19
-$1.53M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RLYB | Director | — | $15.92 | — | $0 | 5 | 2025-05-15 |
| HYPERION THERAPEUTICS INC (HPTX) Delisted | SVP & Chief Commercial Officer | 0 | — | — | -$1.53M | 14 | 2015-05-08 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-05-15 | RLYB | Grant (A) | — | $0 | EDGAR |
| 2024-05-17 | RLYB | Grant (A) | — | $0 | EDGAR |
| 2023-05-19 | RLYB | Grant (A) | — | $0 | EDGAR |
| 2022-05-26 | RLYB | Grant (A) | — | $0 | EDGAR |
| 2022-04-06 | RLYB | Grant (A) | — | $0 | EDGAR |
| 2015-05-08 | HYPERION THERAPEUTICS INC (HPTX) Delisted | Mixed | −96,090 | -$4.42M | EDGAR |
| 2015-05-05 | HYPERION THERAPEUTICS INC (HPTX) Delisted | Exer (M) | +59,087 | $293.4K | EDGAR |
| 2015-03-17 | HYPERION THERAPEUTICS INC (HPTX) Delisted | Mixed | — | -$334.8K | EDGAR |
| 2015-03-13 | HYPERION THERAPEUTICS INC (HPTX) Delisted | Mixed | — | -$310.0K | EDGAR |
| 2015-03-10 | HYPERION THERAPEUTICS INC (HPTX) Delisted | Sell (S) | −9,900 | -$293.3K | EDGAR |